$UHS

Universal Health Services Stock: Analyst Estimates & Ratings

Analysts covering Universal Health Services (UHS) have a consensus rating of 'Moderate Buy,' with six 'Strong Buy' ratings, 13 'Holds,' and one 'Moderate Sell.' The sentiment has shifted from seven 'Moderate Buy' ratings two months ago. RBC Capital analyst Ben Hendrix maintained a 'Sector-Perform' rating, lowering the price target to $183 from $190, implying a 7.3% upside. The mean price target is $192.24, a 9% premium to the current price, while the highest target is $290, suggesting a 64.4% up

Original reporting
Published Aug 26, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Universal Health Services Stock: Analyst Estimates & Ratings — source image
Decision brief

The 30-second read

$UHSBullishMed
01

Why it matters

Analyst consensus and price target revisions could drive short-term buying interest.

02

Market read

Analyst upgrades and higher price targets may support a modest rally in UHS shares.

03

What to watch

Potential impact of upcoming earnings and regulatory changes not reflected in current targets.

Relevance 7/10Novelty 6/10Timing: post-Aug 3 rating update

Background

Universal Health Services (UHS) is a leading provider of acute care and behavioral health services.

Company-level read

Ticker impact

$UHSBullishMedium confidence
Context

Analyst consensus shows a Moderate Buy with price targets up to $290, indicating potential upside.

Expected impact

Modest upside of 5-10% if market reacts to higher targets.

Evidence & confidence

Multiple analysts raised targets; consensus remains supportive, but no new catalyst beyond rating change.

Market effects

Healthcare services sector may see modest uplift as analysts raise targets.

U.S. market could see slight positive bias in hospital REITs.

Limited to U.S. healthcare investors.

Counterpoint

Price targets may be overly optimistic given sector headwinds; hold rating suggests caution.

Key entities

  • RBC Capital

    Trimmed price target to $183, maintaining Sector-Perform rating.

Related articles

$UHSMedAI 8/10

Universal Health Shares Drop 21% YTD: Should You Buy Now?

Universal Health Services (UHS) shares have dropped 20.9% YTD, underperforming peers and the S&P 500. Q2 volumes fell 15% YoY, leading to lowered 2026 guidance. Analysts expect 6.2% EPS growth in 2026. UHS trades at a forward P/E of 7.16X, below peers. The stock has upside potential but faces execution and policy risks.

$UHSMedAI 8/10

Does UHS’s Debt-Funded Talkspace Deal Reshape the Bull Case For Its Digital Behavioral Health Pivot?

Universal Health Services (UHS) completed $1.10 billion in bond offerings and a $26.64 million stock registration. It also used a $400 million loan and revolving credit to acquire Talkspace, increasing its focus on digital behavioral health. The debt-funded deal raises concerns about leverage amid forecasted earnings softness and operational integration risks.

$UHSHighAI 9/10

Universal Health Services Closed Its 835 Million Dollar Talkspace Deal, Linking Virtual Therapy to Inpatient Beds

Universal Health Services (UHS) completed its $835 million acquisition of Talkspace, a virtual therapy platform. UHS operates 380+ behavioral health facilities and reported $17.4B in 2025 revenue. Talkspace has 6,000 providers and reported $229M in 2023 revenue. The deal aims to integrate virtual and inpatient care, addressing clinician shortages and care gaps. UHS expects the acquisition to be slightly accretive to adjusted net income post-closing, excluding purchase costs.

$UHSMedAI 8/10

UHS Adds Talkspace to Accelerate Virtual Behavioral Health Growth

Universal Health Services (UHS) completed its acquisition of Talkspace for $835M, adding 6,000 therapists and expanding virtual behavioral health services. UHS expects the deal to be slightly accretive to EPS within 12 months, with greater benefits thereafter. UHS shares have fallen 6.6% over the past year, underperforming the industry. Talkspace's digital platform complements UHS's in-person care, offering growth opportunities in virtual higher-acuity services.

$UHSMed

UHS Cuts 2026 Profit Outlook Despite Revenue Growth

Universal Health Services (UHS) reported Q2 revenue up 8.3% to $4.64B and net income attributable to UHS of $358.4M ($5.98/share). Despite growth, it cut the 2026 adjusted EPS and adjusted EBITDA outlook midpoints by 2.6% and 1.9%, citing changing Medicaid reimbursements and operating trends. It also reported first-half revenue up 8.9% to $9.13B.

Universal Health Services Stock: Analyst Estimates & Ratings — alphai